USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
USANA HEALTH SCIENCES INC
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 13, 2026
$14.89−0.65 (-4.18%)
Close on Oct 19, 2026
- Market cap
- $275.26M
- P/E (TTM)
- –
- Dividend yield
- –
Usana Health Sciences statistics
Financials through Jul 4, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Market Cap | $275.12M | $164.85M |
| Enterprise Value | $106.56M | $87.06M |
| PS Ratio | 0.30 | 3.60 |
| PB Ratio | 0.52 | 2.03 |
| P/TBV Ratio | 0.94 | 2.31 |
| P/FCF Ratio | 17.27 | 17.44 |
| P/OCF Ratio | 9.92 | 13.32 |
Enterprise value
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| EV / Sales | 0.12 | 2.43 |
| EV / EBITDA | 3.40 | 14.69 |
| EV / FCF | 6.69 | 20.97 |
Income (trailing twelve months)
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Revenue | $913.36M | $57.94M |
| Gross Profit | $707.36M | $90.47M |
| Operating Income | -$1.08M | -$21.44M |
| Pretax Income | $2.54M | -$14.45M |
| Net Income | -$22.16M | -$22.46M |
| EBITDA | $31.35M | -$16.91M |
| EPS (Diluted) | -$1.21 | -$0.83 |
Margins
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Gross Margin | 77.4% | 52.3% |
| Operating Margin | -0.12% | -44.5% |
| Pretax Margin | 0.28% | -13.0% |
| Profit Margin | -2.43% | -39.2% |
| EBITDA Margin | 3.43% | -31.3% |
| FCF Margin | 1.74% | -8.85% |
Returns
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -4.19% | -53.1% |
| Return on Assets (ROA) | -3.08% | -41.0% |
| Return on Invested Capital (ROIC) | -0.15% | -32.0% |
| Return on Capital Employed (ROCE) | -0.18% | -37.8% |
Growth
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.57% | 6.01% |
| Net Income Growth (YoY) | -165.0% | -37.7% |
| EPS Growth (YoY) | -167.2% | -29.2% |
| FCF Growth (YoY) | -68.7% | 2.34% |
| Revenue Growth (3Y CAGR) | -2.51% | 2.25% |
| Revenue Growth (5Y CAGR) | -4.00% | 6.42% |
| EPS Growth (3Y CAGR) | -45.5% | -0.17% |
| EPS Growth (5Y CAGR) | -37.0% | 3.77% |
Balance sheet
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $168.56M | $62.42M |
| Net Cash (Debt) | $168.56M | $15.68M |
| Net Cash Per Share | $9.12 | $0.66 |
| Equity (Book Value) | $526.31M | $48.79M |
| Book Value Per Share | $28.49 | $1.36 |
| Tangible Book Value | $292.55M | $23.06M |
| Working Capital | $175.39M | $75.77M |
Financial position
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Current Ratio | 2.66 | 3.30 |
| Quick Ratio | 1.63 | 2.39 |
| Interest Coverage | -2.62 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | $27.73M | -$12.35M |
| Capital Expenditures | -$11.79M | -$1.06M |
| Free Cash Flow | $15.93M | -$20.28M |
| FCF Per Share | $0.86 | -$0.42 |
Efficiency
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Asset Turnover | 1.27 | 0.38 |
| Inventory Turnover | 2.43 | 2.67 |
| Revenue Per Employee | $581.76K | $398.96K |
| Profits Per Employee | -$14.12K | -$703.34K |
| Employee Count | 1,570 | 74 |
Dividends and yields
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Earnings Yield | -8.06% | -22.7% |
| FCF Yield | 5.79% | -9.07% |
| Buyback Yield | 0.00% | -0.73% |
| Shareholder Yield | 0.00% | 0.00% |
Shares
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 18,476,500 | 58,179,650 |
| Shares Change (YoY) | -3.08% | 11.1% |
| Shares Change (QoQ) | 0.03% | 0.54% |
| Float | 10,921,800 | 49,173,100 |
| Shares Held by Insiders | 40.9% | 11.6% |
| Shares Held by Institutions | 66.2% | 59.4% |
Taxes
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Income Tax | $31.79M | $91.50K |
| Effective Tax Rate | 1253.3% | 20.6% |
Scores
| Measure | Usana Health Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 3.74 | -0.24 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from Usana Health Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.